DrugPatentWatch Database Preview
Karyopharm Theraps Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for KARYOPHARM THERAPS, and what generic alternatives to KARYOPHARM THERAPS drugs are available?
KARYOPHARM THERAPS has one approved drug.
There are five US patents protecting KARYOPHARM THERAPS drugs.
There are eighty patent family members on KARYOPHARM THERAPS drugs in thirty-two countries.
Summary for Karyopharm Theraps
| International Patents: | 80 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Karyopharm Theraps
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-001 | Jul 3, 2019 | RX | Yes | Yes | 9,714,226 | Start Trial | Y | Y | Start Trial | ||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-001 | Jul 3, 2019 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-001 | Jul 3, 2019 | RX | Yes | Yes | 8,999,996 | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Karyopharm Theraps Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20140062480 | Start Trial |
| South Africa | 201700880 | Start Trial |
| Hong Kong | 1198478 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
